By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Doloromics has built a world-class pain therapeutics team with extensive subject matter expertise and decades of combined experience in foundational neuroscience as well as pharmaceutical drug discovery and development. We are dedicated to bringing highly efficacious and safe solutions to millions of pain patients worldwide.

Team Members

Lucas Rodriguez, PhD
Chief Executive Officer
Veteran Drug Hunter and Biotech Executive, Strategy and Execution, Executive Leadership
Candler Paige, PhD
Chief Operating Officer, Director of Investor Relations
Neuropharmacologist, Precision Medicine Expert, NIH Award Recipient, Co-Founder
Jackson Brougher, PhD
Chief Scientific Officer
DOLOReS Architect and Strategist, Early Target Discovery and Validation, Co-Founder
Christopher Flores, PhD
Chief Research and Development Officer, President
20-Year Veteran of Drug Discovery and External Innovation, Deep Domain Expertise, Co-Founder
Lucas Rodriguez, PhD
Chief Executive Officer
Veteran Drug Hunter and Biotech Executive, Strategy and Execution, Executive Leadership
Candler Paige, PhD
Chief Operating Officer, Director of Investor Relations
Neuropharmacologist, Precision Medicine Expert, NIH Award Recipient, Co-Founder
Jackson Brougher, PhD
Chief Scientific Officer
DOLOReS Architect and Strategist, Early Target Discovery and Validation, Co-Founder
Christopher Flores, PhD
Chief Research and Development Officer, President
20-Year Veteran of Drug Discovery and External Innovation, Deep Domain Expertise, Co-Founder

Advisors/Mentors

Advisors/
Mentors

No items found.
Doloromics is on a
revolutionary mission to end human suffering